Rezolute (RZLT) Inventory (2013 - 2015)

Rezolute recorded quarterly Inventory of $186758.0 in Q3 2015, up 177.84% quarter-over-quarter from $67218.0 in Q2 2015, and down 38.14% year-over-year from $301902.0 in Q3 2014.

Rezolute's Inventory history runs 3 years deep, the most recent figure standing at $186758.0 for Q3 2015.

  • In Q3 2015, Inventory fell 38.14% year-over-year to $186758.0; the TTM figure through Sep 2015 stood at $186758.0 (down 38.14% YoY), while the FY2015 annual figure was $67218.0, down 76.79% from the prior year.
  • Inventory came in at $186758.0 for Q3 2015 at Rezolute, up from $67218.0 in the prior quarter.
  • In the past five years, Inventory ranged from a high of $301902.0 in Q3 2014 to a low of $67218.0 in Q2 2015.
  • A 3-year average of $193548.9 and a median of $223000.0 in 2013 frame the typical range for Inventory.
  • Across the five-year window, Inventory soared 35.38% in 2014 and tumbled 76.79% in 2015, its largest moves.
  • Rezolute's Inventory stood at $223000.0 in 2013, then sank by 65.86% to $76135.0 in 2014, then jumped by 145.3% to $186758.0 in 2015.
  • According to Business Quant data, Inventory over the past three periods registered $186758.0, $67218.0, and $92425.0 for Q3 2015, Q2 2015, and Q1 2015 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inventory (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 32.00 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 1.77 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 3.10 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 84.03 Mn
10 Rezolute 374.41 Mn 374.41 Mn - -

Historic Data

Download Data 🔒
DateValue
Sep 30, 2015 186,758.00
Jun 30, 2015 67,218.00
Mar 31, 2015 92,425.00
Dec 31, 2014 76,135.00
Sep 30, 2014 301,902.00
Jun 30, 2014 289,600.00
Mar 31, 2014 223,000.00
Dec 31, 2013 223,000.00
Sep 30, 2013 223,000.00
Jun 30, 2013 223,000.00
Mar 31, 2013 223,000.00